1270480

FTY720

United States Pharmacopeia (USP) Reference Standard

• 别名: 2-氨基-2- [2-（4-辛基-苯基）-乙基]-丙烷-1,3-二醇 盐酸盐, 芬戈莫德 盐酸盐
• 经验公式（希尔记法）: C₁₉H₃₃NO₂ · HCl
• CAS号: 162359-56-0
• 分子量: 343.93
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 生物源: synthetic
• agency: USP
• API 家族: fingolimod
• 形狀: powder
• 製造商／商標名: USP
• 儲存條件: protect from light
• 顏色: white
• 溶解度: DMSO: soluble; ethyl acetate: soluble; water: soluble
• 應用: pharmaceutical
• 儲存溫度: 2-8°C
• InChI: 1S/C19H33NO2.ClH/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22;/h9-12,21-22H,2-8,13-16,20H2,1H3;1H
• InChI 密鑰: SWZTYAVBMYWFGS-UHFFFAOYSA-N

说明

一般說明

Fingolimod Hydrochloride (fingolimod HCl), an S1P-receptor modulator, belongs to the class of synthetic glucocorticoid steroid drugs.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Fingolimod Hydrochloride USP reference standard may be used to quantify the analyte in gel, capsule and other pharmaceutical formulations, active pharmaceutical ingredient (API) and pharmaceutical dosage forms by liquid chromatography (LC) based techniques.

生化／生理作用

FTY720是一种免疫调节药物以及1-磷酸鞘氨醇（S1P）受体的调节剂。 鞘氨醇激酶对FTY270的磷酸化可导致S1P1R的内化，从而螯合淋巴结中的淋巴细胞，阻止它们参与自身免疫反应。 临床上，它已被批准用于治疗多发性硬化症（MS）。研究显示其可通过抑制S1PR阻断和逆转紫杉醇诱导的化疗诱导的周围神经病变（CIPN），并可抑制小鼠脑海马中组蛋白脱乙酰酶的活性，从而调节记忆。

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS08
• 訊號詞: Warning
• 危險聲明: H373
• 防範說明: P260 - P314 - P501
• 危險分類: STOT RE 2
• 標靶器官: Immune system
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable